/Passle/5f3d6e345354880e28b1fb63/SearchServiceImages/2025-03-21-09-53-38-217-67dd3722f016db2f4cd15c95.jpg)
Various UK pharmaceutical companies yesterday co-signed a report warning that future UK investment is unlikely unless the Government...
/Passle/5f3d6e345354880e28b1fb63/SearchServiceImages/2025-03-17-14-22-08-450-67d830102c113a118a323c20.jpg)
On Friday, the DHSC published the latest consultation to update the repayment percentage under the Statutory Scheme. This consultation...
/Passle/5f3d6e345354880e28b1fb63/SearchServiceImages/2025-03-12-14-32-10-309-67d19aea5746d2ef9a9b9626.jpg)
HMRC has been granted permission to appeal the First-Tier Tribunal’s VAT decision in the case of Boehringer Ingelheim Ltd v HMRC. We...
/Passle/5f3d6e345354880e28b1fb63/SearchServiceImages/2024-12-19-12-21-24-651-67640fc43e67bad811f6af68.jpg)
On 16 December, the DHSC announced that the 2025 headline VPAG repayment percentage for sales of “newer medicines” will be 22.9%. This...